Evaluation and construction of diagnostic criteria for inclusion body myositis

Neurology

Volumn 83, Issue 5, 2014, Pages 426-433

  Lloyd, Thomas E ^a   Mammen, Andrew L ^a   Amato, Anthony A ^b   Weiss, Michael D ^c   Needham, Merrilee ^d   Greenberg, Steven A ^b,e  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^e HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTIFICIAL INTELLIGENCE; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOSITIS, INCLUSION BODY; RETROSPECTIVE STUDIES;

EID: 84905819302     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000000642     Document Type: Article

References (15)

1. Calabrese LH, Mitsumoto H, Chou SM. Inclusion body myositis presenting as treatment-resistant polymyositis. Arthritis Rheum 1987;30:397-403.
2. Dalakas MC. Polymyositis, dermatomyositis and inclusionbody myositis. N Engl J Med 1991;325:1487-1498.
3. Mastaglia FL, Phillips BA. Idiopathic inflammatory myopathies: epidemiology, classification, and diagnostic criteria. Rheum Dis Clin North Am 2002;28:723-741.
4. Tawil R, Griggs RC. Inclusion body myositis. Curr Opin Rheumatol 2002;14:653-657.
5. Griggs RC, Askanas V, DiMauro S, et al. Inclusion body myositis and myopathies. Ann Neurol 1995;38:705-713.
6. Verschuuren JJ, Badrising UA, Wintzen AR, van Engelen BG, van der Hoeven H, Hoogendijk JE. Inclusion body myositis. In: Emery AEH, editor. Diagnostic Criteria for Neuromuscular Disorders. London: Royal Society of Medicine Press, European Neuromuscular Centre; 1997:81-84. Available at: http://ibmmyositis.com/ emery81.pdf. Accessed January 26, 2014.
7. Badrising UA, Maat-Schieman M, van Duinen SG, et al. Epidemiology of inclusion body myositis in the Netherlands: a nationwide study. Neurology 2000;55: 1385-1387.
8. Hilton-Jones D, Miller A, Parton M, Holton J, Sewry C, Hanna MG. Inclusion body myositis: MRC Centre for Neuromuscular Diseases, IBM Workshop, London, June 13, 2008. Neuromuscul Disord 2010;20: 142-147.
9. Benveniste O, Hilton-Jones D. International Workshop on Inclusion Body Myositis held at the Institute of Myology, Paris, on May 29, 2009. Neuromuscul Disord 2010; 20:414-421.
10. Rose MR. 188th ENMC International Workshop: Inclusion Body Myositis, 2-4 December, 2011, Naarden, The Netherlands. Neuromuscul Disord 2013;23:1044-1055.
11. Curk T, Demsar J, Xu Q, et al. Microarray data mining with visual programming. Bioinformatics 2005;21: 396-398.
12. Lotz BP, Engel AG, Nishino H, Stevens JC, Litchy WJ. Inclusion body myositis: observations in 40 patients. Brain 1989;112:727-747.
13. Brady S, Squier W, Hilton-Jones D. Clinical assessment determines the diagnosis of inclusion body myositis independently of pathological features. J Neurol Neurosurg Psychiatry 2013;84:1240-1246.
14. Cox FM, Titulaer MJ, Sont JK, Wintzen AR, Verschuuren JJ, Badrising UA. A 12-year follow-up in sporadic inclusion body myositis: an end stage with major disabilities. Brain 2011;134:3167-3175.
15. Needham M, James I, Corbett A, et al. Sporadic inclusion body myositis: phenotypic variability and influence of HLA-DR3 in a cohort of 57 Australian cases. J Neurol Neurosurg Psychiatry 2008;79:1056-1060.